Chemoenzymatic preparative separation of silybins A and B

[1]  Xinxin Li,et al.  Preparative chromatographic purification of diastereomers of silybin and their quantification in human plasma by liquid chromatography-tandem mass spectrometry. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[2]  R. Agarwal,et al.  Gram-scale purification of flavonolignan diastereoisomers from Silybum marianum (Milk Thistle) extract in support of preclinical in vivo studies for prostate cancer chemoprevention. , 2007, Planta medica.

[3]  V. Křen,et al.  Silybin and silymarin--new and emerging applications in medicine. , 2007, Current medicinal chemistry.

[4]  R. Večeřa,et al.  Effect of silymarin and its polyphenolic fraction on cholesterol absorption in rats. , 2006, Pharmacological research.

[5]  V. Křen,et al.  Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation. , 2005, Toxicology.

[6]  V. Křen,et al.  Silybin and silymarin--new effects and applications. , 2005, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[7]  R. Agarwal,et al.  Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. , 2005, Cancer research.

[8]  V. Křen,et al.  Oxidised derivatives of silybin and their antiradical and antioxidant activity. , 2004, Bioorganic & medicinal chemistry.

[9]  D. Y. Lee,et al.  Molecular structure and stereochemistry of silybin A, silybin B, isosilybin A, and isosilybin B, Isolated from Silybum marianum (milk thistle). , 2003, Journal of natural products.

[10]  Nam-Cheol Kim,et al.  Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum). , 2003, Organic & biomolecular chemistry.

[11]  V. Lawrence,et al.  Milk thistle for the treatment of liver disease: a systematic review and meta-analysis. , 2002, The American journal of medicine.

[12]  Z. Zhang,et al.  Determination of active component in silymarin by RP-LC and LC/MS. , 2001, Journal of pharmaceutical and biomedical analysis.

[13]  V. Křen,et al.  Chemoenzymatic preparation of silybin beta-glucuronides and their biological evaluation. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[14]  V. Křen,et al.  Silymarin: What is in the name …? An appeal for a change of editorial policy , 2000, Hepatology.

[15]  V. Křen,et al.  Enzymatic synthesis of iso-globotriose from partially protected lactose☆ , 1999 .

[16]  H. Rosen,et al.  Milk Thistle (Silybum marianum) for the Therapy of Liver Disease , 1998, American Journal of Gastroenterology.

[17]  H. Becker,et al.  CALLUS– UND SUSPENSIONSKULTUREN VON SILYBUM MARIANUM , 1977 .

[18]  F. Fraschini,et al.  Pharmacology of Silymarin , 2002 .

[19]  C. Mulrow,et al.  Milk thistle: effects on liver disease and cirrhosis and clinical adverse effects. , 2000, Evidence report/technology assessment.

[20]  R. Gebhardt,et al.  Glycosylation of silybin , 1997 .

[21]  P. Morazzoni,et al.  Silybum marianum (Carduus marianus) , 1995 .